MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-MP-23-0015606
Sellwell Pharmaceuticals Limited - pharma in Madhya Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2026
₹12.5 Cr
▼ 32% YoY
Net loss · FY 2026
₹13.7 Lakh
Net margin -1.1%
EBITDA · FY 2026
₹89.68 Lakh
EBITDA margin 7.2%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹55.72 Lakh
Issued & subscribed
Open charges
₹6.58 Cr
Satisfied ₹3.36 Cr
Company age
37 yrs
Est. 1989
Employees · EPFO
29
Provident fund records
About Sellwell Pharmaceuticals Limited
Data last updated:
Sellwell Pharmaceuticals Limited is a public limited company based in Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 August 1989 and has been in existence for over 37 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24232MP1989PLC005424. Its GSTIN is 23AACCS7895L1ZQ (Madhya Pradesh).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹55.72 Lakh. It was formerly known as Sellwell Pharmaceuticals Private Limited. It is led by directors including Kamal Karamchandani (Managing Director) and Harish Kumar Matlani.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 92 – Sectore Esanwer Road Indore, Madhya Pradesh, India.
As per the financials filed for FY 2026, the company reported a revenue of ₹12.5 Cr, a decline of 32% compared to the previous year. For the same year it recorded a net loss of ₹13.7 Lakh (net margin -1.1%) and EBITDA of ₹89.68 Lakh (EBITDA margin 7.2%). Revenue has declined at a compounded annual rate (CAGR) of 29% over three years and 16% over five years.
The company has about 29 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹6.58 Cr and satisfied charges of ₹3.36 Cr on record. Court records list 1 case involving the company, including 1 filed by the company.
Sellwell Pharmaceuticals Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-MP-23-0015606). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sellwellpharma.com.
Company details
CIN U24232MP1989PLC005424
Registration Number 005424
Incorporation Date 14 August 1989
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-MP-23-0015606
Key People
Kamal Karamchandani Managing Director Harish Kumar Matlani Director Muskan Karamchandani Director Recognitions & Rankings of Sellwell Pharmaceuticals
Contact details
Sellwell Pharmaceuticals Limited's registered office is in Madhya Pradesh. Its website is sellwellpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address92 – Sectore Esanwer Road Indore, Madhya Pradesh, India
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sellwell Pharmaceuticals Limited, buy the company report.
Comprehensive company report
Sellwell Pharmaceuticals Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Sellwell Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Sellwell Pharmaceuticals Limited, buy the company report.
Financials of Sellwell Pharmaceuticals Limited
FY 2026 filings availableSellwell Pharmaceuticals Limited reported revenue of ₹12.5 Cr (down 32% YoY) for FY 2026.
Revenue · FY 2026
₹12.5 Cr ▼ 32%
Net loss · FY 2026
₹13.7 Lakh margin -1.1%
EBITDA · FY 2026
₹89.68 Lakh margin 7.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 32%
3 years · compounded
▼ 29%
5 years · compounded
▼ 16%
EBITDA CAGR growth
1 year
▼ 11%
3 years · compounded
▼ 22%
5 years · compounded
▼ 15%
Revenue has declined at a compounded annual rate (CAGR) of 16% over five years, including a 32% fall in the latest year. EBITDA fell 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹12.5 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹89.68 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹13.7 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.2% | ||||
| Net Profit Margin | -1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sellwell Pharmaceuticals Limited, buy the company report.
Board of directors of Sellwell Pharmaceuticals Limited
Sellwell Pharmaceuticals has 3 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Harish Kumar Matlani | Director | 28 Mar 2019 | 7 Years 7 Months | Current |
| Muskan Karamchandani | Director | 23 Mar 2012 | 14 Years 7 Months | Current |
| Kamal Karamchandani | Managing Director | 23 Mar 2012 | 14 Years 7 Months | Current |
Auditor
Sellwell Pharmaceuticals Limited is audited by M.KHANDELWAL & COMPANY for the financial year 2026.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M.KHANDELWAL & COMPANY | FY 2026 | 000333C |
Shareholding
The shareholding of Sellwell Pharmaceuticals Limited is on record for 5 financial years, the latest being FY 2026, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sellwell Pharmaceuticals Limited, buy the company report.
Charges & borrowings
Open charges
₹6.58 Cr
Satisfied charges
₹3.36 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 02 Jul 2024 | 100953152 | Axis Bank Limited | ₹4.3 Lakh | Open | |
| 28 Jun 2021 | 100466086 | Axis Bank Limited | ₹12.75 Lakh | Open | |
| 28 Nov 2016 | 100076668 | Axis Bank Limited | ₹6.41 Cr | Open | |
| 27 May 2016 | 100031012 | Others | ₹25 Lakh | Satisfied | |
| 06 Jan 2015 | 10545025 | Cosmos Co-Operative Bank Ltd. | ₹13 Lakh | Satisfied |
To see the full charge records of Sellwell Pharmaceuticals Limited, buy the company report.
Total charge records: 9 View all charges
Legal cases
Sellwell Pharmaceuticals Limited has 1 court case on record: 1 filed by Sellwell Pharmaceuticals. All case is disposed.
Total cases
1
Filed by the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Karnataka | Writ petition | Filed by the company against State of Karnataka | Disposed |
To see the full case history of Sellwell Pharmaceuticals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sellwell Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Sellwell Pharmaceuticals Limited has a workforce of 29 employees on its EPFO records as of Mar 26, 2025, across 1 active EPFO establishment.
Employee count
29
Active EPFO establishments
1
Employee growth
-6.45%
GST
Sellwell Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AACCS7895L1ZQ | Madhya Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sellwell Pharmaceuticals Limited, buy the company report.
Recent activity
Sellwell Pharmaceuticals Limited has 10 board changes on record since 2012: 3 appointments and 7 cessations. The latest: Kamal Karamchandani ceased to be Managing Director on 29 Dec 2020.
Filing
Sellwell Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Gwalior.
Charges
A charge with Axis Bank Limited of Rs. 6.41 Cr registered on 28 Nov 2016 with Charge ID 100076668 was modified on 22 Sep 2025.
AGM
Sellwell Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge with Axis Bank Limited amounted to Rs. 0.04 Cr with Charge ID 100953152 was registered on 02 Jul 2024.
Charges
A charge with Axis Bank Limited amounted to Rs. 0.13 Cr with Charge ID 100466086 was registered on 28 Jun 2021.
Ceased
Kamal Karamchandani ceased to be Managing Director.
Ceased
Harish Kumar Matlani ceased to be Additional Director.
Appointed
Harish Kumar Matlani was appointed as Director.
Charges
A charge registered on 21 Jul 1999 via Charge ID 90208459 with Cosmos Co-Operative Bank Ltd. was fully satisfied on 04 Apr 2017.
Charges
A charge registered on 27 May 2016 via Charge ID 100031012 with Others was fully satisfied on 02 Dec 2016.
Charges
A charge with Axis Bank Limited amounted to Rs. 6.41 Cr with Charge ID 100076668 was registered on 28 Nov 2016.
Charges
A charge with Others amounted to Rs. 0.25 Cr with Charge ID 100031012 was registered on 27 May 2016.
19 earlier events are in the company report.
Frequently asked questions
Sellwell Pharmaceuticals is an active public limited company based in Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 August 1989 (37+ years old) and is registered under CIN U24232MP1989PLC005424.
Sellwell Pharmaceuticals has 3 current directors:
- Kamal Karamchandani - Managing Director
- Harish Kumar Matlani - Director
- Muskan Karamchandani - Director
The latest financial statements of Sellwell Pharmaceuticals on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Sellwell Pharmaceuticals is 23AACCS7895L1ZQ, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Sellwell Pharmaceuticals is U24232MP1989PLC005424. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sellwell Pharmaceuticals has 1 court case on record: 1 filed by the company.
Sellwell Pharmaceuticals was incorporated on 14 August 1989, making it 37+ years old. It is registered with the Registrar of Companies, Gwalior.
Kamal Karamchandani ceased to be Managing Director on 29 Dec 2020. Harish Kumar Matlani ceased to be Additional Director on 30 Sep 2019. Harish Kumar Matlani was appointed as Director on 28 Mar 2019. Sellwell Pharmaceuticals has 10 board changes on record in total.
Yes, Sellwell Pharmaceuticals is registered as an MSME under Udyam registration (number: UDYAM-MP-23-0015606).
Sellwell Pharmaceuticals can be reached through the website sellwellpharma.com. Its registered office is in Madhya Pradesh, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages